urapidil has been researched along with Lung Diseases, Obstructive in 6 studies
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urapidil is known to be an alpha 1-adrenoceptor antagonist and an agonist of central 5HT1A-receptors, and should be considered as a vasodilator." | 5.29 | Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. ( Adnot, S; Samoyeau, R; Weitzenblum, E, 1995) |
| "Urapidil is known to be an alpha 1-adrenoceptor antagonist and an agonist of central 5HT1A-receptors, and should be considered as a vasodilator." | 1.29 | Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. ( Adnot, S; Samoyeau, R; Weitzenblum, E, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wiessmann, KJ | 1 |
| Münninghoff, J | 1 |
| Krüger, C | 1 |
| Späh, F | 1 |
| Kottman, R | 1 |
| Schmidt, U | 1 |
| Adnot, S | 2 |
| Samoyeau, R | 1 |
| Weitzenblum, E | 1 |
| Lewczuk, J | 1 |
| Wrabec, K | 1 |
| Cazzola, M | 1 |
| Spinazzi, A | 1 |
| Santangelo, G | 1 |
| Steinijans, VW | 1 |
| Wurst, W | 1 |
| Solleder, P | 1 |
| Girbino, G | 1 |
| Andrivet, P | 1 |
| Piquet, J | 1 |
| Brun-Buisson, C | 1 |
| Rauss, A | 1 |
| Bignon, J | 1 |
| Lemaire, F | 1 |
1 review available for urapidil and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Value of vasodilator agents in the treatment of diseases with pulmonary hypertension caused by chronic obstructive lung diseases].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel B | 1991 |
3 trials available for urapidil and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Effects of single intravenous administration of urapidil and diltiazem in patients with nonfixed pulmonary hypertension secondary to chronic obstructive lung disease.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Diltiazem; Femal | 1994 |
Acute effects of urapidil on airway response in hypertensive patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Antihypertensive Agents; Female; Forced Expiratory Volume; Humans; Hypertension; Lung D | 1990 |
The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Carbon Dioxide; Clinical Trials as Topic; Forced Expi | 1988 |
2 other studies available for urapidil and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Antihypertensive therapy using urapidil in patients with obstructive lung diseases].
Topics: Adult; Aged; Antihypertensive Agents; Blood Gas Analysis; Drug Evaluation; Female; Hemodynamics; Hum | 1983 |
Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive | 1995 |